Seikagaku Corporation 4548.T Stock
Seikagaku Corporation Price Chart
Seikagaku Corporation 4548.T Financial and Trading Overview
Seikagaku Corporation stock price | 755 JPY |
Previous Close | 759 JPY |
Open | 759 JPY |
Bid | 765 JPY x 0 |
Ask | 768 JPY x 0 |
Day's Range | 759 - 768 JPY |
52 Week Range | 745 - 978 JPY |
Volume | 149.4K JPY |
Avg. Volume | 66.15K JPY |
Market Cap | 41.78B JPY |
Beta (5Y Monthly) | 0.351724 |
PE Ratio (TTM) | 20.974808 |
EPS (TTM) | 24.55 JPY |
Forward Dividend & Yield | 26 (3.40%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | N/A |
4548.T Valuation Measures
Enterprise Value | 13.28B JPY |
Trailing P/E | 20.974808 |
Forward P/E | 23.71517 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.248759 |
Price/Book (mrq) | 0.62155503 |
Enterprise Value/Revenue | 0.397 |
Enterprise Value/EBITDA | 3.859 |
Trading Information
Seikagaku Corporation Stock Price History
Beta (5Y Monthly) | 0.351724 |
52-Week Change | -3.43% |
S&P500 52-Week Change | 20.43% |
52 Week High | 978 JPY |
52 Week Low | 745 JPY |
50-Day Moving Average | 799 JPY |
200-Day Moving Average | 851.27 JPY |
4548.T Share Statistics
Avg. Volume (3 month) | 66.15K JPY |
Avg. Daily Volume (10-Days) | 84.56K JPY |
Shares Outstanding | 54.54M |
Float | 37.68M |
Short Ratio | N/A |
% Held by Insiders | 32.44% |
% Held by Institutions | 20.89% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 26 |
Trailing Annual Dividend Yield | 3.42% |
5 Year Average Dividend Yield | 223.00% |
Payout Ratio | 0.6303 |
Last Split Factor | 15:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 6.68% |
Operating Margin (ttm) | 6.31% |
Gross Margin | 53.87% |
EBITDA Margin | 10.28% |
Management Effectiveness
Return on Assets (ttm) | 1.75% |
Return on Equity (ttm) | 3.34% |
Income Statement
Revenue (ttm) | 33.46B JPY |
Revenue Per Share (ttm) | 605.65 JPY |
Quarterly Revenue Growth (yoy) | 8.79% |
Gross Profit (ttm) | N/A |
EBITDA | 3.44B JPY |
Net Income Avi to Common (ttm) | 2.24B JPY |
Diluted EPS (ttm) | 36.52 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 28.78B JPY |
Total Cash Per Share (mrq) | 527.64 JPY |
Total Debt (mrq) | 389M JPY |
Total Debt/Equity (mrq) | 0.58 JPY |
Current Ratio (mrq) | 6.973 |
Book Value Per Share (mrq) | 1232.393 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.57B JPY |
Levered Free Cash Flow (ttm) | -1724875008 JPY |
Profile of Seikagaku Corporation
Country | Japan |
State | N/A |
City | Tokyo |
Address | Marunouchi Center Building |
ZIP | 100-0005 |
Phone | 81 3 5220 8950 |
Website | https://www.seikagaku.co.jp |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 975 |
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates in two segments, Pharmaceuticals and LAL. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN, OPEGAN Hi, and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and cross-linked hyaluronate hydrogel for knee osteoarthritis under the brand name Gel-One, as well as HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals, biological products, medical devices, manufacturing processes, and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Further, the company develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for osteoarthritis; SI-613-ETP to treat enthesopathy; and SI-449, a powdered adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.
Q&A For Seikagaku Corporation Stock
What is a current 4548.T stock price?
Seikagaku Corporation 4548.T stock price today per share is 755 JPY.
How to purchase Seikagaku Corporation stock?
You can buy 4548.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Seikagaku Corporation?
The stock symbol or ticker of Seikagaku Corporation is 4548.T.
Which industry does the Seikagaku Corporation company belong to?
The Seikagaku Corporation industry is Medical Devices.
How many shares does Seikagaku Corporation have in circulation?
The max supply of Seikagaku Corporation shares is 54.56M.
What is Seikagaku Corporation Price to Earnings Ratio (PE Ratio)?
Seikagaku Corporation PE Ratio is 30.75356500 now.
What was Seikagaku Corporation earnings per share over the trailing 12 months (TTM)?
Seikagaku Corporation EPS is 24.55 JPY over the trailing 12 months.
Which sector does the Seikagaku Corporation company belong to?
The Seikagaku Corporation sector is Healthcare.
Seikagaku Corporation 4548.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}